Literature DB >> 8755498

Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope.

W Xu1, A D Ellington.   

Abstract

In vitro selection of nucleic acid binding species (aptamers) is superficially similar to the immune response. Both processes produce biopolymers that can recognize targets with high affinity and specificity. While antibodies are known to recognize the sequence and conformation of protein surface features (epitopes), very little is known about the precise interactions between aptamers and their epitopes. Therefore, aptamers that could recognize a particular epitope, a peptide fragment of human immunodeficiency virus type I Rev, were selected from a random sequence RNA pool. Several of the selected RNAs could bind the free peptide more tightly than a natural RNA ligand, the Rev-binding element. In accord with the hypothesis that protein and nucleic acid binding cusps are functionally similar, interactions between aptamers and the peptide target could be disrupted by sequence substitutions. Moreover, the aptamers appeared to be able to bind peptides with different solution conformations, implying an induced fit mechanism for binding. Just as anti-peptide antibodies can sometimes recognize the corresponding epitope when presented in a protein, the anti-peptide aptamers were found to specifically bind to Rev.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755498      PMCID: PMC38769          DOI: 10.1073/pnas.93.15.7475

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  The conformational specificity of viral epitopes.

Authors:  M H Van Regenmortel
Journal:  FEMS Microbiol Lett       Date:  1992-12-15       Impact factor: 2.742

2.  How can peptide vaccines work?

Authors:  D J Rowlands
Journal:  FEMS Microbiol Lett       Date:  1992-12-15       Impact factor: 2.742

3.  In vitro selection of an RNA epitope immunologically cross-reactive with a peptide.

Authors:  D E Tsai; D J Kenan; J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

4.  Structural evidence for induced fit as a mechanism for antibody-antigen recognition.

Authors:  J M Rini; U Schulze-Gahmen; I A Wilson
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

5.  RNA recognition by Tat-derived peptides: interaction in the major groove?

Authors:  K M Weeks; D M Crothers
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

6.  RNA recognition by an isolated alpha helix.

Authors:  R Tan; L Chen; J A Buettner; D Hudson; A D Frankel
Journal:  Cell       Date:  1993-06-04       Impact factor: 41.582

7.  Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A.

Authors:  R L Stanfield; T M Fieser; R A Lerner; I A Wilson
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

8.  Conformation of the TAR RNA-arginine complex by NMR spectroscopy.

Authors:  J D Puglisi; R Tan; B J Calnan; A D Frankel; J R Williamson
Journal:  Science       Date:  1992-07-03       Impact factor: 47.728

9.  The single-stranded DNA aptamer-binding site of human thrombin.

Authors:  L R Paborsky; S N McCurdy; L C Griffin; J J Toole; L L Leung
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

10.  Specific binding of a basic peptide from HIV-1 Rev.

Authors:  J Kjems; B J Calnan; A D Frankel; P A Sharp
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

View more
  30 in total

1.  Anti-Rex aptamers as mimics of the Rex-binding element.

Authors:  S Baskerville; M Zapp; A D Ellington
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

2.  Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer.

Authors:  J Colin Cox; Andrew Hayhurst; Jay Hesselberth; Travis S Bayer; George Georgiou; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

3.  Characterization of RNA determinants recognized by the arginine- and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation.

Authors:  David Khoo; Cesar Perez; Ian Mohr
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX.

Authors:  Axel Vater; Florian Jarosch; Klaus Buchner; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

5.  In vitro selection of ribozymes dependent on peptides for activity.

Authors:  Michael P Robertson; Scott M Knudsen; Andrew D Ellington
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

Review 6.  Recent advances in understanding oligonucleotide aptamers and their applications as therapeutic agents.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Mohammed A Alsahli; Ghaiyda Talal Basfar; Faris Alrumaihi; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  3 Biotech       Date:  2020-11-24       Impact factor: 2.406

7.  A DNA Spiegelmer to staphylococcal enterotoxin B.

Authors:  Werner G Purschke; Falko Radtke; Frank Kleinjung; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

8.  The arginine-rich RNA-binding motif of HIV-1 Rev is intrinsically disordered and folds upon RRE binding.

Authors:  Fabio Casu; Brendan M Duggan; Mirko Hennig
Journal:  Biophys J       Date:  2013-08-20       Impact factor: 4.033

9.  A polycatenated DNA scaffold for the one-step assembly of hierarchical nanostructures.

Authors:  Yossi Weizmann; Adam B Braunschweig; Ofer I Wilner; Zoya Cheglakov; Itamar Willner
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

10.  In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor.

Authors:  H Ulrich; J E Ippolito; O R Pagán; V A Eterović; R M Hann; H Shi; J T Lis; M E Eldefrawi; G P Hess
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.